Back

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease

2026-02-18 neurology Title + abstract only
View on medRxiv
Show abstract

Lysosomal dysfunction is central to Parkinsons disease pathogenesis, with GBA1 as the strongest established genetic risk factor. Numerous other genes involved in lysosomal sphingolipid, glycosphingolipid and ceramide metabolism have been proposed as contributors to Parkinsons disease, underscoring the need for comprehensive genetic analyses across these pathways. We analysed rare variants (minor allele frequency < 0.01) across 36 lysosomal genes (excluding GBA1) in 8,267 individuals with Parkins...

Predicted journal destinations